Anterior Minimal Invasive Surgery Versus Antero-lateral Approach in Hip Joint Hemiarthroplasty

• Sponsor: Rehabilitation Hospital Tobelbad (Other)
• Overall Status: Completed
• CT.gov ID: NCT05255198
• Collaborator: (none)
• Enrollment: 83
• Actual Duration (Months): 37

Study Details

Study Description

Brief Summary

Comparison between two minimally invasive approaches to the hip joint.

Condition or Disease	Intervention/Treatment	Phase
Arthroplasty; Clinical Outcome	Procedure: Anterior versus lateral approach to hip joint

Detailed Description

Following parameters were compared: modified Barthel-Index, pain, complications, developing of heterotopic ossification.

Study Design

• Study Type: Observational [Patient Registry]
• Actual Enrollment: 83 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Anterior Minimal Invasive Surgery Versus Antero-lateral Approach in Hip Joint Hemiarthroplasty
• Actual Study Start Date: May 1, 2016
• Actual Primary Completion Date: May 31, 2019
• Actual Study Completion Date: May 31, 2019

Arms and Interventions

Arm	Intervention/Treatment
Anterolateral approach	Procedure: Anterior versus lateral approach to hip joint
Direct anterior approach	Procedure: Anterior versus lateral approach to hip joint

Outcome Measures

Primary Outcome Measures

1. Visual Analogue Scale [one year after surgery]

   Pain score

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Exclusion Criteria:

Exclusion criteria represented acute local or systemic infection, open or pathological fractures, concomitant injuries of the ipsi- or contralateral leg and rheumatoid arthritis.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Rehabilitation Hospital Tobelbad

Investigators

None specified.

Study Documents (Full-Text)

• Study Protocol and Statistical Analysis Plan - Dec 21, 2015
• Informed Consent Form - Dec 21, 2015

More Information

Publications

None provided.

• Responsible Party: Renate Krassnig MD PhD, Consultant, Rehabilitation Hospital Tobelbad
• ClinicalTrials.gov Identifier: NCT05255198
• Other Study ID Numbers: HHAP$1
• First Posted: Feb 24, 2022
• Last Update Posted: Feb 24, 2022
• Last Verified: Feb 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Feb 24, 2022